MedTrace Logo

Healthcare Utilization and Costs Among Hospitalized Patients With Cardiomyopathy

NCT06893731 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15764

Last updated 2026-05-20

No results posted yet for this study

Summary

Cardiomyopathy is the most common inherited cardiovascular disease, showing family aggregation, and it has a huge psychological and economic burden on family members. In this study, the investigators collected clinical information and costs of patients hospitalized with cardiomyopathy and establish a database to characterize real-world cost profile and inform cost management of cardiomyopathy.

Conditions

  • Cardiomyopathies
  • Cost

Sponsors & Collaborators

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2022-03-01
Completion
2026-02-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06893731 on ClinicalTrials.gov